Smart Insulin Pens Sales

Smart Insulin Pens Sales Market Outlook

The global smart insulin pens market is projected to reach USD 2.5 billion by 2035, exhibiting a compound annual growth rate (CAGR) of 12.5% from 2025 to 2035. The increasing prevalence of diabetes, particularly type 1 and type 2 diabetes, is driving the demand for advanced insulin delivery systems, with smart insulin pens offering precision, convenience, and enhanced patient monitoring. The integration of technology in diabetes management, such as Bluetooth connectivity and app synchronization, is also positively influencing market growth by promoting adherence to insulin therapy and facilitating continuous glucose monitoring. Furthermore, an aging population and the rise in obesity rates globally are contributing to the growing incidence of diabetes, which in turn is expected to boost the market for smart insulin pens significantly. The shift towards personalized medicine and the need for better patient outcomes are also encouraging advancements in smart insulin pen technologies, thereby propelling market growth.

Growth Factor of the Market

The smart insulin pens market is experiencing significant growth primarily driven by the increasing incidence of diabetes worldwide. Diabetes has become a global health crisis, with millions of individuals needing effective management solutions. Smart insulin pens, equipped with advanced features like dose tracking and data sharing capabilities, cater to these needs by providing users with greater control over their diabetes management. Additionally, the growing awareness of the importance of proper insulin dosing and adherence to therapy is steering patients towards smart insulin pens as an essential tool in their treatment arsenal. Moreover, innovations in technology, such as the incorporation of artificial intelligence and machine learning to optimize insulin delivery, are expected to further enhance user experience and efficacy. The convenience of these devices, which often sync with smartphones or cloud applications, provides patients and healthcare providers with actionable insights that can improve treatment outcomes, adding to the overall demand for smart insulin pens.

Key Highlights of the Market

• Increasing prevalence of diabetes globally prompting demand for advanced insulin delivery systems.
• Technological advancements integrating Bluetooth and mobile applications enhance user convenience.
• Rising awareness about adherence to insulin therapy promotes the adoption of smart insulin pens.
• Personalized medicine trends in diabetes care support the growth of innovative insulin delivery solutions.
• Aging population and rising obesity rates contribute to the heightened incidence of diabetes.

By Product Type

Bluetooth-enabled Smart Insulin Pens:

Bluetooth-enabled smart insulin pens represent a significant segment within the smart insulin pens market, providing users with the ability to connect their pen with mobile applications for enhanced tracking and data management. This connectivity allows patients to monitor insulin doses, receive reminders for medication, and share data with healthcare providers seamlessly. The integration of Bluetooth technology facilitates real-time communication between the pen and a smartphone, promoting better adherence to insulin therapy. These pens often have features such as dose memory and error alerts, further enhancing user experience. The convenience offered by Bluetooth-enabled smart insulin pens is a key factor driving their popularity among diabetes patients.

USB-connected Smart Insulin Pens:

USB-connected smart insulin pens allow users to directly connect to computers or mobile devices for data transfer and analysis. This type of smart insulin pen is particularly beneficial for patients who prefer a more traditional method of data management without relying on wireless technology. The USB connection enables users to download their insulin dosing history and glucose levels, allowing for better insights into their diabetes management. Furthermore, these pens often come equipped with software that interprets the data, facilitating better discussions with healthcare professionals. USB connectivity provides a straightforward solution for patients who may not be as tech-savvy, thereby broadening the overall market appeal.

Memory-enabled Smart Insulin Pens:

Memory-enabled smart insulin pens are designed to store critical dosing information, including the amount of insulin delivered and the timing of doses. This feature is particularly useful for individuals who may have difficulty remembering their insulin regimen. By maintaining a detailed log of insulin administration, these pens help patients and healthcare providers identify patterns and adjust treatment plans accordingly. Furthermore, the ability to review past dosing history can facilitate discussions during medical consultations, enhancing the overall quality of diabetes management. The convenience of having an integrated memory system makes these pens appealing for many users, thereby contributing to their market growth.

Dose Calculator Smart Insulin Pens:

Smart insulin pens equipped with dose calculators are emerging as a valuable tool for diabetes patients who require precise insulin dosing based on their carbohydrate intake or blood glucose levels. These pens automatically calculate the correct insulin dosage, reducing the risk of human error that can occur with manual calculations. This technological advancement not only improves patient safety but also fosters better adherence to insulin therapy. Users benefit from the ability to make informed dosing decisions quickly, leading to improved glycemic control. The increasing focus on personalized diabetes management is driving interest in dose calculator smart insulin pens within the market.

Temperature Monitored Smart Insulin Pens:

Temperature-monitored smart insulin pens are designed to ensure that the insulin remains effective by monitoring its storage conditions. Insulin is sensitive to temperature extremes, and these pens provide alerts if temperatures fall outside the safe range. This feature is particularly crucial for patients who travel or may have fluctuating storage conditions. By protecting insulin integrity, temperature-monitored pens help to minimize the risks associated with ineffective insulin, ultimately leading to better health outcomes. As awareness of the importance of proper insulin storage grows, the demand for temperature-monitored smart insulin pens is expected to increase.

By Application

Type 1 Diabetes:

The application of smart insulin pens in managing Type 1 diabetes is a critical segment of the market. Type 1 diabetes, being an autoimmune condition, requires individuals to administer insulin multiple times a day to maintain blood glucose levels. Smart insulin pens enhance the quality of life for these patients by providing accurate dosing, reminders, and tracking features that help them manage their condition effectively. The ability to sync with smartphone applications allows for better monitoring of blood glucose levels and insulin use, facilitating timely adjustments to therapy. As the number of Type 1 diabetes patients continues to grow, the demand for smart insulin pens specifically designed for this group is expected to rise.

Type 2 Diabetes:

Type 2 diabetes management is another significant application area for smart insulin pens. Patients with Type 2 diabetes often require insulin therapy as their condition progresses, making smart insulin pens essential for effective management. These pens provide users with features that promote adherence to prescribed regimens, leading to better overall glycemic control. The combination of insulin delivery and data tracking offered by smart insulin pens empowers patients to take an active role in their healthcare. Additionally, the rising incidence of Type 2 diabetes globally is contributing to the growth of this segment within the smart insulin pens market.

Gestational Diabetes:

Gestational diabetes is a temporary form of diabetes that occurs during pregnancy, and its management is crucial for the health of both the mother and the baby. Smart insulin pens are increasingly being utilized in this application as they allow for easy and accurate insulin administration. The convenience of these devices for expecting mothers, combined with their data tracking capabilities, can help prevent complications associated with gestational diabetes. Healthcare providers can also benefit from the data provided by smart insulin pens, allowing them to adjust treatment plans more effectively. As awareness and diagnosis of gestational diabetes rise, the demand for smart insulin pens in this application is likely to grow.

By Distribution Channel

Hospital Pharmacies:

Hospital pharmacies play a pivotal role in the distribution of smart insulin pens, particularly for patients receiving treatment within hospital settings. These pharmacies are essential for ensuring that patients have access to the latest insulin delivery technologies upon discharge. The presence of healthcare professionals in hospital pharmacies allows for proper education and training on the use of smart insulin pens, improving patient outcomes post-discharge. Furthermore, the collaboration between hospital pharmacies and diabetes care teams helps facilitate timely adjustments to insulin therapy based on the patient's immediate health status. As hospitals continue to adopt advanced diabetes management tools, the significance of hospital pharmacies in the smart insulin pen market will remain strong.

Retail Pharmacies:

Retail pharmacies are a key distribution channel for smart insulin pens, providing patients with convenient access to diabetes management tools. These pharmacies cater to the general public, making it easier for individuals to obtain smart insulin pens while managing their daily errands. The availability of these devices in retail settings also allows for greater consumer education on their benefits and usage, enhancing patient engagement. Retail pharmacies often run promotions and offer consultations to improve awareness of smart insulin pens, aiding in the uptake of these technologies. As diabetes prevalence continues to rise, retail pharmacies will play an increasingly important role in the distribution of smart insulin pens.

Online Pharmacies:

Online pharmacies have emerged as a vital distribution channel for smart insulin pens, especially amidst the growing trend of e-commerce and digital health solutions. The convenience of ordering products from the comfort of home, coupled with the ability to access a wider range of diabetes management tools, is driving the popularity of online pharmacies. Patients often find online pharmacies to be a more discreet option for purchasing medical supplies, including smart insulin pens. Furthermore, the integration of telehealth services with online pharmacies allows for virtual consultations, ensuring that patients receive the necessary guidance in using their smart insulin devices. As the digital economy expands, the influence of online pharmacies on the smart insulin pen market is expected to grow significantly.

By Connectivity Type

Wireless Smart Insulin Pens:

Wireless smart insulin pens are gaining traction in the market due to their ability to connect effortlessly with mobile devices via Bluetooth or other wireless technologies. This connectivity allows users to track their insulin doses and blood glucose levels through dedicated applications, providing real-time data and reminders. The convenience and user-friendliness of wireless technology appeal to patients who are tech-savvy and seek seamless integration of diabetes management tools into their daily lives. The growing emphasis on digital health solutions and personalized medicine is further driving the adoption of wireless smart insulin pens, making them a prominent segment in the market.

Wired Smart Insulin Pens:

Wired smart insulin pens, typically using USB or similar connections, offer a more traditional method for data transfer and management. While these devices may not provide the same level of convenience as their wireless counterparts, they still serve an essential function, especially for users who prefer a straightforward approach. Wired smart insulin pens allow patients to connect to computers or other devices for downloading and analyzing their dosing information. This method can be particularly beneficial for patients who are not comfortable with wireless technology or prefer to keep their diabetes management offline. Consequently, wired smart insulin pens continue to maintain relevance in the overall market.

Smartphone App Integrated Smart Insulin Pens:

Smart insulin pens integrated with smartphone applications represent a growing trend in diabetes management. These pens offer the advantage of a comprehensive digital platform that allows users to log their insulin doses, monitor their blood glucose levels, and receive personalized insights regarding their diabetes management. The integration with smartphone apps fosters better communication between patients and healthcare providers, enabling data-sharing that can inform treatment adjustments. The popularity of smartphone applications among users enhances the appeal of these smart insulin pens, making them an increasingly desirable option in the market.

Cloud-based Smart Insulin Pens:

Cloud-based smart insulin pens are revolutionizing the way diabetes is managed by allowing users to store and analyze their data in the cloud. This technology provides patients and healthcare providers with centralized access to vital health information, promoting collaboration in treatment planning. Cloud-based solutions facilitate long-term monitoring and trend analysis of insulin usage and blood glucose levels, leading to more informed decision-making. The security and convenience associated with cloud-based data storage encourage patients to adopt these pens, contributing to their growth in the market. As cloud computing technology advances, the integration of smart insulin pens with cloud systems is likely to become a standard feature, increasing their market presence.

NFC-enabled Smart Insulin Pens:

NFC-enabled smart insulin pens utilize near-field communication technology to facilitate quick data transfer between the pen and compatible devices. This capability allows users to upload their dosing information to smartphones or tablets with just a tap, enhancing the user experience and promoting adherence to therapy. The convenience offered by NFC technology caters to the modern patient demographic, which increasingly values ease of use and efficiency in their healthcare tools. With the growing demand for instant data sharing and real-time monitoring, NFC-enabled smart insulin pens are expected to become more popular, further driving market expansion.

By Region

The smart insulin pens market is witnessing regional variations in growth and demand due to differing healthcare systems, diabetes prevalence, and technological adoption rates. In North America, the market is projected to grow significantly, driven by the high prevalence of diabetes and the increasing adoption of advanced healthcare technologies. The United States alone accounts for a large percentage of the global diabetes population, leading to a robust demand for smart insulin pens. The CAGR in this region is anticipated to be around 13%, reflecting the growing focus on improving diabetes management outcomes through innovative technologies. Meanwhile, Europe is also expected to contribute substantially to market growth, with rising awareness of diabetes management tools and supportive healthcare policies promoting the use of smart insulin pens.

In the Asia Pacific region, the smart insulin pens market is poised for rapid expansion, propelled by the rising incidence of diabetes and increasing healthcare expenditures. Countries such as China and India are witnessing a surge in diabetes cases due to lifestyle changes and urbanization, thus driving the demand for smart insulin pens. Additionally, the growing middle-class population in these countries is enhancing access to healthcare technologies, including smart insulin pens. Latin America and the Middle East & Africa are also expected to experience steady growth, although at a relatively slower pace compared to North America and Europe. These regions are gradually adopting smart diabetes management tools, aided by improvements in healthcare infrastructure and awareness campaigns focused on diabetes care. Overall, the global market for smart insulin pens is on an upward trajectory, driven by technological advancements and increasing healthcare demands.

Opportunities

The smart insulin pens market presents numerous opportunities for growth, especially in light of the increasing prevalence of diabetes globally. With millions of individuals diagnosed with diabetes, there is a pressing need for efficient insulin delivery systems that can improve patient outcomes. As technological advancements continue to emerge, companies have the opportunity to develop innovative features within smart insulin pens, such as integration with wearable devices and artificial intelligence for personalized insulin dosing. Furthermore, partnerships between technology firms and healthcare providers can foster the development of comprehensive diabetes management solutions that cater to the unique needs of patients. The growing focus on preventive care and chronic disease management also creates avenues for smart insulin pens to play a pivotal role in enhancing the quality of care delivered to patients.

In addition to technological advancements, the increasing awareness of diabetes management among patients and healthcare professionals presents significant opportunities for market players. Educational initiatives aimed at promoting the benefits of using smart insulin pens can lead to higher adoption rates among patients. Furthermore, expanding distribution channels, especially online pharmacies and telehealth services, enables patients to access smart insulin pens more conveniently. As telemedicine continues to rise, integrating smart insulin pens into remote monitoring solutions can enhance patient engagement and adherence to therapy. Overall, the smart insulin pens market is poised for growth, driven by emerging opportunities that align with evolving healthcare landscapes and patient needs.

Threats

Despite the promising growth prospects for the smart insulin pens market, there are several threats that could hinder its progress. One of the most significant threats stems from the inherent challenges associated with diabetes management, including patient adherence to insulin therapy. Many diabetes patients struggle with consistent self-management and may find it challenging to integrate smart insulin pens into their daily routines. This lack of adherence can result in suboptimal health outcomes, thereby affecting the overall market demand for such devices. Additionally, the high cost of advanced smart insulin pens compared to traditional insulin delivery methods may deter some patients from making the switch, particularly in regions with limited healthcare budgets.

Another critical threat to the market is the regulatory landscape that governs medical devices, which can vary significantly across different countries and regions. Stringent regulatory requirements and lengthy approval processes can slow down the introduction of new smart insulin pen technologies to the market. Furthermore, data privacy and security concerns related to the digital health components of smart insulin pens pose risks that could affect consumer confidence. If patients are apprehensive about sharing their health data with third-party applications, it may hinder the widespread adoption of these devices. Consequently, stakeholders in the smart insulin pen market must navigate these challenges carefully to ensure sustainable growth and continued innovation.

Competitor Outlook

• Medtronic
• Sanofi
• Roche
• Novo Nordisk
• Insulet Corporation
• Diabeloop
• Ypsomed
• Boehringer Ingelheim
• Bigfoot Biomedical
• SmartDose
• Glooko
• Hugo Health
• Valeritas
• Medisafe
• Diabetes Care Club

The competitive landscape of the smart insulin pens market is characterized by the presence of numerous established companies and emerging players striving to innovate and capture market share. Major firms such as Medtronic, Novo Nordisk, and Roche are leading the way with their advanced smart insulin pen technologies and comprehensive diabetes management solutions. These companies invest heavily in research and development to create products that enhance patient experience and improve health outcomes. Their strong brand recognition and established distribution networks provide them with a competitive edge in the market. Furthermore, partnerships and collaborations with healthcare providers and technology firms are common among these players, facilitating the development of integrated solutions that cater to the evolving needs of diabetes patients.

Emerging companies like Bigfoot Biomedical and Diabeloop are also making significant strides in the smart insulin pen market by focusing on innovative technologies and personalized treatment options. These startups often leverage cutting-edge advancements in artificial intelligence and machine learning to deliver more effective insulin delivery systems. Their agility and willingness to embrace new ideas allow them to disrupt traditional market dynamics and offer patients unique solutions that enhance their diabetes management. As the market continues to evolve, these emerging players are expected to contribute to the overall growth and diversification of smart insulin pen technologies.

Key players in the smart insulin pen market, such as Sanofi and Insulet Corporation, are recognized for their commitment to improving patient outcomes through user-friendly designs and reliability. Sanofi, for example, has been at the forefront of diabetes care, developing innovative insulin delivery systems that minimize complexity for users. Insulet Corporation's Omnipod system is notable for its tubeless insulin pump technology that eliminates the need for traditional injection methods, thereby improving user experience. These companies are focusing on expanding their product portfolios by integrating new features and enhancing their devices' connectivity capabilities, further positioning themselves as industry leaders.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Roche
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Glooko
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Sanofi
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Ypsomed
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Medisafe
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Diabeloop
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Medtronic
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 SmartDose
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Valeritas
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Hugo Health
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Novo Nordisk
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Bigfoot Biomedical
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Diabetes Care Club
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Insulet Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Boehringer Ingelheim
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Smart Insulin Pens Sales Market, By Application
    • 6.1.1 Type 1 Diabetes
    • 6.1.2 Type 2 Diabetes
    • 6.1.3 Gestational Diabetes
  • 6.2 Smart Insulin Pens Sales Market, By Product Type
    • 6.2.1 Bluetooth-enabled Smart Insulin Pens
    • 6.2.2 USB-connected Smart Insulin Pens
    • 6.2.3 Memory-enabled Smart Insulin Pens
    • 6.2.4 Dose Calculator Smart Insulin Pens
    • 6.2.5 Temperature Monitored Smart Insulin Pens
  • 6.3 Smart Insulin Pens Sales Market, By Connectivity Type
    • 6.3.1 Wireless Smart Insulin Pens
    • 6.3.2 Wired Smart Insulin Pens
    • 6.3.3 Smartphone App Integrated Smart Insulin Pens
    • 6.3.4 Cloud-based Smart Insulin Pens
    • 6.3.5 NFC-enabled Smart Insulin Pens
  • 6.4 Smart Insulin Pens Sales Market, By Distribution Channel
    • 6.4.1 Hospital Pharmacies
    • 6.4.2 Retail Pharmacies
    • 6.4.3 Online Pharmacies

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Smart Insulin Pens Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Smart Insulin Pens Sales market is categorized based on

By Product Type

• Bluetooth-enabled Smart Insulin Pens
• USB-connected Smart Insulin Pens
• Memory-enabled Smart Insulin Pens
• Dose Calculator Smart Insulin Pens
• Temperature Monitored Smart Insulin Pens

By Application

• Type 1 Diabetes
• Type 2 Diabetes
• Gestational Diabetes

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Connectivity Type

• Wireless Smart Insulin Pens
• Wired Smart Insulin Pens
• Smartphone App Integrated Smart Insulin Pens
• Cloud-based Smart Insulin Pens
• NFC-enabled Smart Insulin Pens

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Medtronic
• Sanofi
• Roche
• Novo Nordisk
• Insulet Corporation
• Diabeloop
• Ypsomed
• Boehringer Ingelheim
• Bigfoot Biomedical
• SmartDose
• Glooko
• Hugo Health
• Valeritas
• Medisafe
• Diabetes Care Club